Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RXST · against 234 other Healthcare companies of similar size
Ranked #107 of 235 · scores higher than 55% of peers · safety percentile 57
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)24 peers with a safety percentile of 50–59, including RXST · Click a bar to see the companies
A mix: stronger debt / equity and current ratio, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | RXST | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 207 reported | 0.04× | 0.21× | 75% | 33% | |
| BetaLower is better · 222 reported | 1.16 | 0.60 | 22% | 33% | |
| Current ratioHigher is better · 230 reported | 4.07× | 3.07× | 59% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 186M USD | 100 | 52 | |
| 2 | 165M USD | 99 | 50 | |
| 3 | 261M USD | 99 | 97 | |
| 4 | 2.7B CNY (≈$375M) | 99 | 67 | |
| 5 | 2.3B CNY (≈$318M) | 99 | 68 | |
| 103 | 302M USD | 59 | 42 | |
| 104 | 37.3B JPY (≈$254M) | 58 | 66 | |
| 105 | 100M USD | 58 | 37 | |
| 106 | 171.0B KRW (≈$123M) | 58 | 41 | |
| 107 | 191M USD | 57 | 38 | |
| 108 | 7.1B TWD (≈$221M) | 57 | 25 | |
| 109 | 336M EUR (≈$369M) | 56 | 31 | |
| 110 | 1.9B CNY (≈$262M) | 56 | 24 | |
| 111 | 1.9B CNY (≈$264M) | 56 | 27 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score